Indofarma | Income Statement
Fiscal year is January-December. All values IDR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,337,498
1,381,437
1,621,899
1,674,703
1,631,317
1,592,980
Cost of Goods Sold (COGS) incl. D&A
1,001,247
1,083,023
1,298,425
1,347,192
1,371,062
1,328,248
Gross Income
336,251
298,413
323,474
327,510
260,256
264,732
SG&A Expense
353,481
258,024
263,515
287,163
255,129
254,571
EBIT
20,691
-
51,835
33,969
3,203
14,173
Unusual Expense
4,069
-
-
-
-
-
Non Operating Income/Expense
16,446
7,759
4,945
1,233
1,481
36,722
Interest Expense
30,862
38,998
40,779
52,431
52,532
48,166
Pretax Income
63,168
7,769
16,283
18,921
56,817
25,298
Income Tax
8,810
6,329
9,717
1,554
10,532
7,438
Equity in Affiliates
136
-
-
-
-
-
Consolidated Net Income
54,223
1,440
6,566
17,367
46,285
32,736
Net Income
54,222
1,442
6,567
17,367
46,283
32,736
Net Income After Extraordinaries
54,222
1,442
6,567
17,367
46,283
32,736
Net Income Available to Common
54,222
1,442
6,567
17,367
46,283
32,736
EPS (Basic)
17.50
0.47
2.12
5.60
14.93
10.56
Basic Shares Outstanding
3,099
3,099
3,099
3,099
3,099
3,099
EPS (Diluted)
17.50
0.47
2.12
5.60
14.93
10.56
Diluted Shares Outstanding
3,099
3,099
3,099
3,099
3,099
3,099
EBITDA
9,005
61,358
70,501
55,837
31,596
18,831
Other Operating Expense
3,461
1,931
8,124
6,378
8,330
24,334
Non-Operating Interest Income
762
494
257
700
402
288
Minority Interest Expense
-
1
1
1
2
1
Equity in Affiliates (Pretax)
-
55
26
74
2
32
About Indofarma
View Profile
